No direct host molecular target

The term "No direct host molecular target" refers to a pharmacological classification for therapeutic agents that achieve their clinical effects through physical or chemical processes rather than by interacting with specific host proteins like receptors, enzymes, or transporters (StatPearls, 2023). Common examples include antacids, which neutralize gastric acid via simple acid-base stoichiometry, and osmotic laxatives like polyethylene glycol, which create a solute gradient to retain water in the intestinal lumen (NIH, 2022). Other agents in this category include physical adsorbents like activated charcoal, which traps toxins in the gastrointestinal tract to prevent systemic absorption, and chelating agents that bind to heavy metals or specific ions (WHO, 2021). Some specialized drugs like sugammadex also fall into this category by encapsulating drug molecules (rocuronium) in the plasma rather than acting on a host receptor (PubChem, 2024). Because these mechanisms are governed by physical laws or chemical reactions, they are generally less affected by genetic variations in host target proteins but can significantly alter the pharmacokinetics of other medications. This classification is essential for distinguishing non-targeted therapies from traditional drug-receptor interactions in clinical pharmacology.

Other names

Non-receptor mediated mechanismPhysicochemical drug actionNon-specific drug actionChemical neutralizationPhysical drug action

Drugs in this category exert therapeutic effects through direct chemical reactions, physical changes in the environment, or sequestration of molecules rather than by binding to host proteins such as receptors or enzymes.